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Deoxyhypusine hydroxylase (DOHH) is a non-heme
diiron enzyme involved in the posttranslational modi-
fication of a critical lysine residue of eukaryotic trans-
lation initiation factor 5A (eIF-5A) to yield the unusual
amino acid residue hypusine. This modification is
essential for the role of eIF-5A in translation and in
nuclear export of a group of specific mRNAs. The
diiron center of human DOHH (hDOHH) forms a
peroxo-diiron(III) intermediate (hDOHHperoxo) when
its reduced form reacts with O2. hDOHHperoxo has a
lifetime exceeding that of the peroxo intermediates
of other diiron enzymes by several orders of magni-
tude. Here we report the 1.7-A˚ crystal structures of
hDOHHperoxo and a complex with glycerol. The struc-
ture of hDOHHperoxo reveals the presence of a
m-1,2-peroxo-diiron(III) species at the active site.
Augmented byUV/Vis andMo¨ssbauer spectroscopic
studies, the crystal structures offer explanations for
the extreme longevity of hDOHHperoxo and illustrate
how the enzyme specifically recognizes its only sub-
strate, deoxyhypusine-eIF-5A.
INTRODUCTION
Translation initiation factor 5A (eIF-5A) is a ubiquitous protein of
monomeric molecular mass of around 18 kDa. It is present in
archaea and eukaryotes but not in prokaryotes (Park, 2006). A
highly conserved lysine residue located in an exposed position
in the N-terminal domain of eIF-5A undergoes a unique post-
translational modification, hypusination. Hypusination of eIF-5A
is achieved in a two-step process involving the enzymes deoxy-882 Structure 23, 882–892, May 5, 2015 ª2015 Elsevier Ltd All rightshypusine synthase (DHS) and deoxyhypusine hydroxylase
(DOHH), resulting in extension of the critical lysine residue by a
1-amino-3-hydroxobutyl moiety to become hypusine (Hpu)
(Park, 2006) (Figure 1).
eIF-5A is the only protein known to be subject to hypusination
(Greganova et al., 2011); this modification is essential for the bio-
logical roles of the protein in translation elongation (Saini et al.,
2009), in particular of polyproline stretches (Gutierrez et al.,
2013). Hypusination of eIF-5A is also essential for nucleocyto-
plasmic mRNA transport of transcripts encoding inducible nitric
oxide synthase and of retroviral mRNA, which are related to islet
b-cell dysfunction (Maier et al., 2010) and retroviral replication
(Hauber et al., 2005), respectively. Furthermore, the degree of
eIF-5A hypusination seems to be relevant for controlling the bal-
ance between cell proliferation and apoptosis (Tome andGerner,
1997; Caraglia et al., 2001, 2013). Prevention of eIF-5A hypusina-
tion through inactivating DHS or DOHH is therefore of interest for
the development of therapies for the treatment of HIV/AIDS,
chronic myeloid leukemia, and diabetes (Kaiser, 2012).
The structure and mechanism of DHS have been extensively
characterized (see Park, 2006, for a review). However, progress
in research on DOHH remains limited. The atomic structure of
DOHH has not been determined although a low-resolution struc-
tural model derived from small-angle X-ray scattering has been
reported for the yeast enzyme (Cano et al., 2010). Circular di-
chroism spectroscopy and amino acid sequence analysis re-
vealed that DOHH is an a-helix-rich protein belonging to the
HEAT-repeat protein family (Park et al., 2006; Kim et al., 2006;
Cano et al., 2010). Molecular modeling and site-directed muta-
genesis suggested that human DOHH (hDOHH) is a non-heme
diiron enzyme featuring highly conserved His-Glu motifs that
offer two potential iron coordination sites (Park et al., 2006;
Kim et al., 2006). Recombinant hDOHH is a mixture of apo-
and holo-enzyme, which displays two close peaks in gel filtration
and different mobilities in native gel electrophoresis (Kim et al.,
2006). A considerable proportion of recombinant hDOHH isreserved
Figure 1. Posttranslational Modification of eIF-5A
Hypusination is a two-step process performed by deoxyhypusine synthase
(DHS) and deoxyhypusine hydroxylase (DOHH). The eIF-5A precursor is
successively converted to deoxyhypusine-eIF-5A (Dhp-eIF-5A) and hypusine-
eIF-5A (Hpu-eIF-5A).apo-enzyme, which in turn exists as a mixture of several confor-
mations as concluded from a diffuse band in native electropho-
resis (Kim et al., 2006).
Recombinant hDOHH is bluish and contains two antiferro-
magnetically coupled, high-spin Fe(III) atoms, as revealed by
Mo¨ssbauer spectroscopy (Vu et al., 2009). The characteristic
chromophore (two absorption bands at lmax 320 nm and
lmax 630 nm) is ascribed to the charge transfer between Fe(III)
and the O2
2 ligand, suggesting that bluish hDOHH is a peroxo
intermediate (hDOHHperoxo) (Vu et al., 2009). Charge-transfer
bands (630–725 nm) and Mo¨ssbauer parameters similar to
those of hDOHHperoxo have been found for the peroxo interme-
diates of soluble methane monooxygenase hydroxylase
(sMMOH) (Liu et al., 1995), ribonucleotide reductase subunit
R2 (RNR-R2) variants (Moe¨nne-Loccoz et al., 1998), stearoyl-
acyl carrier protein D9-desaturase (D9D) (Broadwater et al.,
1998), ferritin (Moe¨nne-Loccoz et al., 1999), and the T201S
variant of toluene/o-xylene monooxygenase hydroxylase
(ToMOH) (T201Speroxo) (Song et al., 2009; Song and Lippard,
2011). The peroxo-diiron(III) intermediates in these enzymes
have been assigned as end-on, bridging peroxo-diiron(III) spe-
cies (m-1,2-peroxo-diiron(III)) based on the structures of biomi-
metic synthetic complexes displaying similar charge-transfer
bands, Mo¨ssbauer parameters, and Raman bands (Kim and
Lippard, 1996; Ookubo et al., 1996; Zhang et al., 2005). In addi-
tion to these peroxo-diiron(III) species, it has also been pro-
posed that the peroxo intermediate is present in the reaction
cycle of wild-type ToMOH (Murray et al., 2007), p-aminoben-
zoate N-oxygenase (AurF) (Korboukh et al., 2009), and alde-
hyde-deformylating oxygenase (ADO) (Pandelia et al., 2013).
However, the peroxo intermediates in these enzymes lack op-
tical bands similar to those of peroxo intermediate of sMMOH
implying that the binding mode of the peroxo unit in the
diiron(III) core of these enzymes is different from that in ferritin
or sMMOH; it likely features a m-1,1-peroxo geometry (Kor-Structure 23boukh et al., 2009). Although it is not an enzyme, oxyhemery-
thrin (oxyHr) also contains a peroxo-diiron(III) species; however,
it has been found that in this case, a non-bridging hydroperoxo
ligand terminally binds to only one iron of the diiron site (Klotz
and Kurtz, 1984; Holmes et al., 1991).
The peroxo-diiron(III) species detected in all non-heme
diiron(III) enzymes exist as transient intermediateswith very short
lifetimes. Therefore, characterization of the peroxo-diiron(III)
species by crystallography is a challenge. After soaking crystals
in H2O2 (a non-biological peroxide-shunt reaction), Bailey and
Fox (2009) reported the structure of a peroxo intermediate of
toluene 4-monooxygenase hydroxylase (T4moH) (in complex
with effector protein). This structure may not represent the native
state of the dioxygen-bound diiron core during O2-activation,
since the peroxo ligand was initially protonated, leading to
differences in the proton balance within the active site (Bailey
and Fox, 2009). Unusually, hDOHHperoxo displays extreme
longevity, as it survives several days after protein purification,
even at room temperature (Vu et al., 2009). Therefore, hDOHH
is an excellent system to structurally investigate the native
biological peroxo-diiron(III) intermediate, thereby providing key
information on the mechanisms of O2-activating non-heme
diiron enzymes. An atomic structure is essential to understand
the structural properties of the transient intermediate as well
as the interaction between hDOHH and its specific substrate,
deoxyhypusine-eIF-5A (Dhp-eIF-5A).
In the study presented here, we crystallized hDOHH and
determined its three-dimensional structure. We present two
crystal structures that correspond to two states of the enzyme,
hDOHHperoxo (POX) and a complex of the diiron core with glyc-
erol (GLC). Both structures have a resolution of 1.7 A˚. For the
first time, the POX structure reveals the atomic details of a
native biological m-1,2-peroxo-diiron(III) intermediate. A unique
diiron coordination and the secondary coordination environ-
ment explain the extreme longevity of hDOHHperoxo. The struc-
ture of the glycerol complex serves as a reference for the
diiron(III) geometry in the resting state, which is useful for com-
parison with the peroxo intermediate of the enzyme. The struc-
tures also illustrate the properties of the substrate-binding
pocket. A model for the hDOHH-Dhp interaction is built on
the basis of a docking experiment.
RESULTS AND DISCUSSION
Holo-Enzyme Isolation and Crystallization
Stepwise truncation of the presumably unstructured C-terminal
region of hDOHH (total number of residues, 302) was applied
in order to increase the chance of crystallizing the enzyme. Trun-
cated hDOHH was overproduced in Escherichia coli as
described in the Experimental Procedures. The pure holo-
enzyme was isolated by repeated gel filtration until the apo-
hDOHH was almost completely removed from isolated hDOHH
(Figure S1A). A construct truncated at Gln289 gave rise to the
best crystallization hit. Crystals were obtained within 6 hr of
setting up the crystallization experiment and were of weak blue
color (Figure S1B). When 10%–20% glycerol was applied as a
crystallization additive, the crystals grew much more slowly,
within 36 hr, and were mostly colorless to light brownish
(Figure S1C)., 882–892, May 5, 2015 ª2015 Elsevier Ltd All rights reserved 883
Figure 2. Spectroscopic Results
(A) Time-dependent UV/Vis absorption spectra
recorded at 10C. The inset shows a magnification
of the absorption peak at long wavelengths.
(B) Mo¨ssbauer spectrum of freshly isolated
hDOHH in solution.
(C) Mo¨ssbauer spectrum of hDOHH polycrystals
grown for 48 hr. The crystallization conditions were
the same as for crystals used for X-ray diffraction
(see Figure S1B).
(D) Mo¨ssbauer spectrum of hDOHH in solution in
the presence of 10% glycerol, 48 hr after isolation.
(E) Mo¨ssbauer spectrum of polycrystals of the
hDOHH-glycerol complex grown for 48 hr. The
crystallization conditions were the same as for
glycerol-containing crystals used for X-ray diffrac-
tion (see Figure S1C).Spectroscopic Studies
The characteristic bluish color of hDOHH (Vu et al., 2009) showed
up immediately after breaking the expression cells. The color per-
sisted during the process of protein purification at 4C. Even if the
protein purification time for individual batches varied from 2 to
5 days, the same profiles in the UV/Vis spectra were observed.
Time-dependent UV/Vis spectra recorded at 10C (the tempera-
ture of crystallization; see below) revealed that the absorption
band at long wavelengths was blue-shifted from lmax 630 nm
to lmax  600 nm within 96 hr, concomitant with a reduction of
molar absorptivity (Figure 2A); at room temperature, this effect
was somewhat stronger (data not shown). The lack of pure iso-
sbestic points in the spectra suggests the presence of more than
one decay species of the initial peroxo intermediate during
the recorded period. The persisting, albeit weaker, blue color
of this hDOHH solution indicates the continued presence of
peroxo-diiron(III) species. Similar blue-shifts of the maximum
absorbance coupled with reduced molar absorptivity have been
ascribed to changes in the protonation state or to a carboxylate
shift in theperoxo-diiron(III) core, for instance in ferritin (Bou-Abdal-
lah et al., 2005) or in synthetic model compounds (Zhang et al.,
2005; Frischetal., 2009). Froman inspectionof theUV/Vis spectra,
we therefore assume that, due to a similar process,more than one
peroxo-diiron(III) species is present in the hDOHH system.
In order to characterize possible changes at the diiron site in
the crystalline state, polycrystals were prepared of the free884 Structure 23, 882–892, May 5, 2015 ª2015 Elsevier Ltd All rights reservedenzyme as isolated and of the glycerol-
containing sample, and subjected to
Mo¨ssbauer spectroscopy. Freshly iso-
lated hDOHH in solution was measured
in parallel as a reference. The latter
gave Mo¨ssbauer parameters d1/2 =
0.57/0.55 mm s1, DEQ1/2 = 0.85/
1.17 mm s1, G1/2 = 0.27/0.24 mm s
1
(Figure 2B), almost identical to the results
reported by Vu et al. (2009). This spec-
trum shows very narrow line widths,
suggesting that our purified hDOHH sam-
ple contains a relatively homogenous
hDOHHperoxo. Crystals of the recombi-
nant enzyme as isolated gave rise to aMo¨ssbauer spectrum slightly different from that obtained from
freshly prepared hDOHH in solution (Figure 2C): isomer shifts
(d1/2 = 0.62/0.62 mm s
1, DEQ1/2 = 0.72/1.25 mm s
1) were
slightly larger than those from freshly prepared hDOHH
in solution but still well within the region typical for m-1,2-
peroxo-diiron(III) species (Friedle et al., 2010). The procedure
of growing crystals within a given timewindow (48 hr) and subse-
quent washing of the crystals with buffer (see Experimental Pro-
cedures) set limits to the measured signal-to-noise effect
(ca. 0.3%). The crystals grown in the presence of glycerol gave
Mo¨ssbauer parameters almost identical to a sample of the
enzyme in solution containing 10% glycerol (Figures 2D
and 2E): d1/2 = 0.54/0.58 mm s
1, DEQ1/2 = 0.74/1.07 mm s
1,
G1/2 = 0.33/0.28 mm s
1 and d1/2 = 0.55/0.56 mm s
1, DE1/2 =
0.77/1.06 mm s1, G1/2 = 0.33/0.34 mm s
1 for crystals and
solution, respectively, which are, however, different from prepa-
rations of the free enzyme. The spectra shown in Figures 2D
and 2E imply that glycerol likely induces some change at the
diiron site of hDOHH. Interestingly, glycerol has been found to
accelerate decay of the peroxo-diiron(III) species in sMMOH
but the reason is unclear (Lee and Lipscomb, 1999).
Crystal Structure Determination and Overall Structure
of hDOHH
For both crystallization conditions, the crystals obtained were
harvested after 48 hr (at 10C) for X-ray diffraction experiments;
Table 1. Crystallographic Data and Refinement Statistics
Crystal 1
(GLC) (Peak)
Crystal 2
(GLC)
Crystal 3
(POX)
Diffraction Data Statistics
X-Ray source BL14.2,
BESSY II
BL14.2,
BESSY II
BL14.2,
BESSY II
Wavelength (A˚) 1.73965 0.91841 0.91841
Space group P21 P21 P21
Unit cell parameters
a, b, c (A˚) 45.97, 70.22,
101.00
46.05, 70.18,
101.28
45.93, 48.64,
124.09
b (degrees) 102.57 102.71 99.27
Resolution
(range) (A˚)a
27.6–1.90
(2.00–1.90)
44.92–1.70
(1.79–1.70)
19.85–1.70
(1.79–1.70)
Reflections 328,812
(44,594)
269,456
(26,602)
193,329
(30,445)
Unique reflections 49,878
(7,266)
68,054
(8,949)
57,441
(8,631)
Rmerge 0.075
(0.260)
0.037
(0.174)
0.049
(0.237)
Rpim
b 0.031
(0.116)
0.021
(0.121)
0.032
(0.148)
CC1/2 0.997
(0.894)
0.999
(0.962)
0.998
(0.938)
I/s(I) 17.1 (6.9) 23.5 (6.0) 14.0 (4.3)
Redundancy 6.6 (6.1) 4.0 (3.0) 3.4 (3.5)
Completeness (%) 99.8 (99.8) 98.2 (89.0) 96.2 (99.7)
Wilson B factor (A˚2) 20.6 17.2 14.9
SigAno 2.00
FOM (DM FOM) 0.694 (0.855)
Refinement Statisticsc
Refinement resolution
range (A˚)
19.95–1.70 19.85–1.70
No. of reflections 64,571 54,485
Rwork/Rfree
(% of reflections)
0.171/0.194
(5.0)
0.203/0.246
(5.0)
Average B factor (A˚2) 20.67 18.90
No. of atoms
Protein 4399 4410
Water 335 440
Other 37 28
Rms deviations
Bond lengths (A˚) 0.022 0.018
Bond angles (degrees) 2.007 1.769
Ramachandran
favored (%)
100.00 99.30
Ramachandran
outliers (%)
0.00 0.00
MolProbity score 1.58 1.78
aThe highest resolution shell is shown in parentheses.
bPrecision-indicatingmergingR factor.Rpim is defined asShkl[1/(N 1)]1/2
SijIi(hkl)  <I(hkl)>j/ShklSiIi(hkl) (Weiss and Hilgenfeld, 1997).
cSee also Table S1.
Figure 3. Ribbon Presentation of the Structure of hDOHH
Helices are labeled. Yellow, inter-domain loop; green, iron atoms. See also
Figures S2 and S3.
Structure 23thus, the structures obtained likely correspond to enzyme sub-
jected to similar aging conditions as the samples used for Mo¨ss-
bauer (crystalline preparations) and UV/Vis (48 hr) spectroscopy.
The crystals grown from the glycerol-free and glycerol-con-
taining conditions share the same space group but display
different unit cell parameters. The refined structures feature
two different states of the diiron core, the peroxo-diiron(III) inter-
mediate (POX) in the crystals grown in the absence of glycerol
and a glycerol-bound diiron complex (GLC) in the crystals grown
in the presence of glycerol. Both structures have a resolution of
1.7 A˚. Table 1 shows a summary of diffraction data collection,
phase determination, and structure refinement.
Both structures (POX and GLC) have an almost identical over-
all architecture. There are two hDOHH monomers (A and B) per
asymmetric unit. The overall structure of the hDOHH monomer
comprises a pseudosymmetric arrangement of an N-terminal
and a C-terminal domain, each consisting of four HEAT repeats
(a-hairpins), accounting for a total of 16 a-helices, as predicted
by sequence analysis (Park et al., 2006) (Figure 3). There is no
related structure in the PDB with 4 + 4 HEAT repeats. In each
of the two domains, the four HEAT motifs stack on top of each
other, with odd-numbered a-helices (a1, 3, 5, 7, and 9, 11, 13,
15) arranged parallel to one another and located toward the exte-
rior of the protein, and even-numbered a-helices (a2, 4, 6, 8, and
10, 12, 14, 16) also arranged parallel to one another and located
in the interior of the protein (Figure 3). The interior a-helix layers
from the two domains pack against each other at an angle of
approximately 45, leaving an opening that runs along the inter-
face in the middle of the protein. A significant deviation between
the POX and GLC structures exists at the C-terminal helices, in
particular a16 (Figure S2). The reorientation of a16 by an angle
of around 15 results in a difference of 6.07 ± 0.15 A˚ for the, 882–892, May 5, 2015 ª2015 Elsevier Ltd All rights reserved 885
Figure 4. Electron Density Maps and Coor-
dination Geometry of the Diiron Core
Carbon, nitrogen, oxygen, and iron atoms are
presented in gray, blue, red, and green, respec-
tively. PER, peroxide ion; W1, water coordinating
to Fe1; W2, water coordinating to Fe2; W3,
bridging water. The electron density maps for
molecule B are presented in Figure S4.
(A) Amino acid residues as diiron core ligands in
hDOHH.
(B) As in (A), in another orientation (180 counter-
clockwise rotation of (A), viewed from the side of
His89 and His207).
(C) Electron density around the iron atoms in chain
A of the POX structure before including the non-
protein ligands: magenta, Fo  Fc map (contoured
at 4.0s); blue, 2Fo  Fc map (at 1.0s).
(D) Electron density map of the diiron core in chain
A of the POX structure after ligand inclusion and
refinement (2Fo  Fc map, at 1.5s, blue mesh).
(E) The diiron core in chain A of the POX structure
with the non-protein ligands included.
(F) As in (C), for the GLC structure.
(G) As in (D), for the GLC structure.
(H) As in (E), for the GLC structure.C-terminal residue, Glu283, of this helix (for the Ca position;
averaged between the two copies in the asymmetric unit).
The N-terminal and the C-terminal domains share 36%
sequence identity (53% similarity) (Figure S3) and the structures
of the two domains can be superimposed with a Ca root-mean-
square (rms) difference of about 0.95 A˚, strongly suggesting that
hDOHH evolved through gene duplication. The two domains are
connected by a long loop (residues 136–157), the conformation
of which is very well conserved between the four copies of
hDOHH (POX and GLC) elucidated within this study (Figure 3).
The loop invaginates into the interior of the protein where it is
involved in several electrostatic interactions. Between the two
domains, near the helix pairs a4/a6 and a12/a14, the diiron cat-
alytic center of hDOHH is located in an orientation parallel to the
axis between the two staples of HEAT repeats (Figure 3).
Diiron Core of hDOHH
The diiron centers of the POX and GLC structures share the
same set of amino acid ligands. Each iron is coordinated by
two histidine residues (through their Nε atoms) and one gluta-
mate; thus, the diiron center of hDOHH displays a histidine-
rich coordination, 4H-2E (Figure 4A). Fe1 is coordinated by
His89, Glu90, and His207, and Fe2 is coordinated by His56,
His240, andGlu241. In previousmutagenesis work, all these res-
idues were found to be essential for maintaining the iron content
and activity of the enzyme (Kim et al., 2006). All amino acid li-
gands of the Fe atoms are monodentate; distinct from other
diiron enzymes (Nordlund and Eklund, 1995; Summa et al.,
1999), there is no bridging glutamate. The coordinative bonds886 Structure 23, 882–892, May 5, 2015 ª2015 Elsevier Ltd All rights reservedto the carboxylate oxygens range from
1.99 to 2.10 A˚, whereas the Fe-N bonds
are between 2.18 and 2.34 A˚. All four his-
tidines coordinate to the same hemi-
sphere of the diiron core and the four Nεatoms from the histidines are approximately arranged in one
plane (Figure 4B).
In the POX structure, the distance between the two Fe atoms
is 3.77 and 3.68 A˚ in the two copies of the enzyme. In a cavity
within the histidine coordination hemisphere, we detected a
well-defined difference density that could be clearly assigned
to a peroxo ligand in an orientation roughly but not exactly par-
allel to the Fe-Fe axis (Figures 4C and 4D; Figures S4A and
S4B). This presumed O2
2 species bridges the irons as a
m-1,2-ligand at distances of 2.23/2.21 A˚ (Fe1) and 2.18/2.17 A˚
(Fe2) (Figure 4E; Table S1). The O-O bond length is 1.54/
1.52 A˚ (for molecules A and B, respectively), and the B factors
for the individual oxygens are almost equal to one another
(Table S1). The Fe-O-O-Fe torsion angles are 58.1 and
31.6 (gauche conformation) in molecules A and B, respec-
tively. In addition, on the opposite side of the Fe-Fe axis, in
the upper coordination hemisphere of the diiron core, there
are three water molecules (W1, W2, and W3) coordinating to
diiron, with W3 bridging the two irons (Figures 4D and 4E).
W3 could also be a bridging hydroxo ion as proposed by Vu
et al. (2009) on the basis of spectroscopic studies and struc-
tures of model complexes.
The Fe-Fe distances of 3.77/3.68 A˚ are within the range
observed in structures of biomimetic complexes, where the
distances vary from 3.17 to 4.00 A˚ (Kim and Lippard, 1996;
Dong et al., 1996; Ookubo et al., 1996; Zhang et al., 2005).
The value of 3.7 A˚ for the POX structure is slightly longer
than the 3.44 A˚ Fe-Fe distance determined for hDOHHperoxo
by extended X-ray absorption fine structure spectroscopy
Figure 5. Residues in the Secondary Coor-
dination Sphere of the DiironCore of hDOHH
(A) The diiron core in hDOHH with the secondary
coordination sphere included. The carbon atoms
of residues in the primary coordination sphere are
cyan, those of residues in the hydrophobic sec-
ondary hemisphere (below the Fe-Fe axis) are
gray, and those in the hydrophilic secondary
hemisphere (above the Fe-Fe axis) are yellow.
(B) Methionine mutations at positions 86 and 237:
SDS-PAGE (bottom) and native PAGE (top).
(C) The methionine pair Met86/Met237 shields the
diiron core from solvent. Both methionines have
been replaced either separately or together by
alanine or leucine in site-directed mutagenesis
experiments (see text and (B)). The figure shows a
model of the modified residues based on the
crystal structure (POX) of wild-type hDOHH. In the
wild-type structure (yellow surfaces for Met86 and
Met237) and the leucine mutants (orange sur-
faces), the iron atoms (green spheres) are shielded
by a pair of large hydrophobic residues (and
consequently not visible in these images), but in
the alanine mutants (magenta surfaces), the iron is
accessible to solvent.(Vu et al., 2009). The elongated Fe-Fe distance in our crystal
structure is possibly due to aging during the process of crystal-
lization (at 10C over 48 hr) that might be accompanied by pro-
tonation of a bridging hydroxyl ion to water (W3) in the diiron
core of POX, which would result in a longer Fe-Fe distance.
Ranging between 2.17 and 2.23 A˚, the Fe-O(peroxo) distances
are longer than the values of 1.86–1.94 A˚ observed in biomi-
metic model complexes (Kim and Lippard, 1996; Ookubo
et al., 1996; Zhang et al., 2005). The elongated Fe-O(peroxo)
distances in the POX structure could result from protonation
of the bridging peroxo unit, as proposed for large Fe-O(peroxo)
distances in the structure of the non-biological T4moH peroxo
intermediate obtained by soaking crystals with H2O2 (Bailey
and Fox, 2009).
In the GLC structure, the Fe-Fe distance has shrunk to 3.44/
3.48 A˚. There is no electron density consistent with the presence
of a peroxo ligand; both Fo - Fc and 2Fo - Fc maps reveal a single
oxygen atom as a bridging ligand in the lower hemisphere and a
glycerol molecule bound to the upper hemisphere of the diiron
core (Figures 4F and 4G; Figures S4C and S4D). In the refined
GLC structure, the distances between Fe and the bridging oxy-
gen are 2.05/1.95 A˚ (Fe1) and 2.21/2.22 A˚ (Fe2) (Table S1).
Fe-O-Fe angles are 107.5 and 113.2 in the two molecules of
the GLC structure, consistent with the bridging oxygen being a
m-hydroxo ligand (Kurtz, 1990). In the other ligation hemisphere,
hydroxyl group 2 (O2) of glycerol replaces W1 of the POX struc-
ture and hydroxyl group 3 (O3) replaces the bridging W3 (Fig-Structure 23, 882–892, May 5, 2015ure 4H). Hydroxyl group 1 (O1) of glycerol
donates a bifurcated hydrogen bond to
the carboxylates of Glu93 and Glu208. A
glycerol-bound diiron site is also present
in the X-ray structure of phenol hydroxy-
lase (PH), but in a different binding
mode, with the O2 of glycerol coordi-nating to Fe1 only and the other two hydroxyl groups not being
involved in iron coordination (McCormick and Lippard, 2011).
Secondary Coordination Sphere of the Diiron Site
in hDOHH
Surrounding the 4H-2E set of ligands, a number of amino acid
side chains constitute a secondary coordination sphere for the
diiron cluster in hDOHH. Like the iron ligands of the inner sphere,
all residues in the secondary coordination sphere are present in
pairs (one mate from each of the two domains) and arranged
symmetrically around the diiron center (Figure 5A). The second-
ary coordination sphere can be divided into a hydrophilic hemi-
sphere above the Fe-Fe axis and a hydrophobic hemisphere
below the Fe-Fe axis (on the peroxo side of the diiron core) in Fig-
ure 5A. In the hydrophilic hemisphere, two glutamate pairs
(Glu57/Glu244 and Glu93/Glu208) are located at each end of
the diiron unit; a hydrogen-bonded tyrosine pair (Tyr60/Tyr211)
is around 9 A˚ (terminal OH group to Fe) above the diiron site.
Alanine substitutions of glutamates 57, 93, and 208 do not affect
the iron content (Kang et al., 2007); nor does the E244Amutation
(Z.H. et al., unpublished data).
In the hydrophobic hemisphere, residue pairs Leu53/Leu204
and Met86/Met237 as well as the four iron-coordinating histi-
dines (His56, His89, His207, and His240) enclose the small
pocket containing the peroxo ligand below the diiron unit, with
Met86 and Met237 shielding the diiron core from solvent (Fig-
ure 5A). The methionine pair is absolutely conserved in DOHH.ª2015 Elsevier Ltd All rights reserved 887
It displays 180 rotational symmetry and is located 5.5 A˚
(Fe-S(Met) distance) away from the diiron unit (Figure 5A). The
electron density maps suggest that there are alternative confor-
mations for the tips of the side chains of Met86 and Met237.
Although Met237 and Met86 are not coordinating the iron
atoms directly, they influence the proper function of hDOHH.
The M237A mutation has been reported to lead to loss of iron
and enzymatic activity (Kang et al., 2007). In separate experi-
ments, we replaced Met86 by alanine and one or both of the me-
thionines by leucine. The mutations M86A and M86L/M237L
lead to serious loss of iron, whereas M237L leads to partial
loss of the metal ions (Figure 5B). Structural modeling of the
methionine mutations shows that the alanine substitutions
make the diiron core solvent accessible but the leucine mutants
do not (Figure 5C). Yet, the presence of at least onemethionine is
required to retain hDOHH in the holo-enzyme state. A possible
role for the methionine pair might be protection of the diiron
core by scavenging reactive oxygen species.
Structural Basis for the Extreme Longevity of the
Peroxo-diiron(III) Intermediate in hDOHH
Generally, the fate of peroxo-diiron(III) species in O2-activating
non-heme diiron enzymes is cleavage of the O-O bond and
concomitant oxidation of the diiron core to high-oxidation-state
diiron species, which are the ones performing the respective cat-
alytic reactions (Wallar and Lipscomb, 1996). The lifetime of the
peroxo-diiron(III) core in enzymes of this kind is very short (half-
life varies from seconds to 30 min) (Table S2). In contrast,
hDOHHperoxo is unusually stable (Figure 2A; Table S2). A
structural comparison of the diiron environment of other
peroxo-diiron(III) enzymes with hDOHH sheds light on the rea-
sons for the extreme longevity of hDOHHperoxo. First, a histi-
dine-rich ligand set (4H-2E) coordinates the diiron unit; all histi-
dines coordinate iron through their Nε atoms; both glutamate
carboxylate groups are terminal ligands for the iron atoms in a
monodentate fashion. All of these features weaken the elec-
tron-donating properties of the iron ligands. Studies with biomi-
metic complexes revealed that cleavage of the O-O bond is
enhanced by introduction of more electron-donating, negatively
charged ligands (Dong et al., 1996). In contrast to hDOHH, the
diiron sites of sMMOH, RNR-R2, and D9D display a carbox-
ylate-rich ligand set, histidines coordinating through their Nd
atoms, and at least one bridging carboxylate (Table S2). Second,
the peroxo unit in hDOHHperoxo is shielded by a unique, highly hy-
drophobic environment (Figure 5A) comprising the four histidines
as well as the residue pairs Met86/Met237 and Leu53/Leu204. A
correlation between the stability of the peroxo species and
the hydrophobicity of its environment has been observed with
small-molecule model compounds. A m-1,2-peroxo-diiron(III)
model complex, in which the peroxo ligands are located in a hy-
drophobic pocket consisting of phenyl groups, shows significant
thermal stability and reversible oxygenation (Ookubo et al.,
1996). In addition, such a hydrophobic environment for the
peroxo unit avoids proton-triggered heterolytic O-O bond cleav-
age. A threonine residue in the vicinity of the diiron sites of
sMMOH, ToMOH, and D9D may play a role in O2 binding and
transferring protons to the peroxo unit (Wallar and Lipscomb,
1996; Bochevarov et al., 2011; Lee et al., 2013). It has been
shown that this threonine accelerates the formation and decay888 Structure 23, 882–892, May 5, 2015 ª2015 Elsevier Ltd All rightsrates of the peroxo intermediates of ToMOH (Song et al.,
2010). The presumably corresponding position in hDOHH is
occupied by the methionine pair, Met86/Met237, which is not a
good candidate for mediating proton transfer.
On the basis of these observations, we propose that the
unique diiron environment in hDOHH blocks the oxygen activa-
tion sequence at the stage of the peroxo-diiron(III) species.
This means that the catalytic core of hDOHH has very limited
ability to break the O-O bond and generate a potent oxidant
for C-H bond cleavage, in agreement with the observed,
extremely low activity of hDOHH in vitro (Vu et al., 2009). The
decay of hDOHHperoxo is accelerated in the presence of protein
substrate (Vu et al., 2009), implying that incorporation of the
Dhp side chain into the diiron site facilitates the electron transfer.
Vu et al. (2009) suggested that perhaps a so far unidentified inter-
action partner exists in vivo that assists the reaction. Alterna-
tively, Nature perhaps chose such a slow enzyme to modulate
the hypusination of eIF-5A, by which cell growth is strictly regu-
lated (Hanauske-Abel et al., 1994).
Although the function of hemerythrin (Hr) is distinct from the
O2-activating non-heme diiron enzymes mentioned above, it is
a good example for illustrating how a non-heme diiron protein
canmaintain the integrity of theO-O bond in the peroxo-diiron(III)
unit. There are many similarities shared by the peroxo-diiron(III)
cores of oxyHr and hDOHH, although the peroxo group binds
to the diiron core in different ways. The diiron unit of Hr is coor-
dinated by five histidine ligands (through their Nε atoms) and two
carboxylate groups (5H-E-D); the peroxo ion is surrounded by a
hydrophobic environment consisting of two leucines, one isoleu-
cine, one phenylalanine, and one tryptophan as well as four iron-
coordinating histidines (Stenkamp, 1994), a similar environment
to that found in hDOHH (Figure 5A). These characteristics prob-
ably allow Hr to function as an O2 carrier.
The Substrate-Binding Cavity of hDOHH
The mouth of a funnel-shaped access cavity to the active site is
located on the surface of hDOHH, on the open side between the
two stacks of HEAT repeats. This opening is between 14.5 and
18 A˚ wide and lined by residues from helix a2 (Gln22, Arg26,
Phe29, Arg32), a12 (Gln215, Gln217), and a16 (Asp278,
Met279, His282, Glu283) as well as by Leu145 and Ser146
from the inter-domain loop (Figure 6A). About 18 A˚ into the cav-
ity, a major constriction of the funnel is reached; through the
arrangement of amino acid side chains from helices a4 (Glu57,
Tyr60), a12 (Tyr211), and a14 (Glu241, Glu244), the diameter is
narrowed to 6.5–9.0 A˚ (Figure 6A). This is the entrance to the in-
ner cavity of the enzyme, which is about 11 A˚ deep and harbors
the diiron active site at one of its walls in an orientation parallel to
the long axis of the cavity (Figure 6B). Residues Glu93 and
Glu208 are at the bottom of the inner cavity. These properties
are in remarkable agreement with an early prediction based on
two inhibitory catechol peptide probes anchored to the metal
ions through their dihydroxybenzene groups (Abbruzzese et al.,
1991).
The dimension of the external cavity is sufficiently wide to
accommodate the exposed loop of eIF-5A that carries the
Dhp residue to be hydroxylated by hDOHH. The inner cavity
is perfectly suited to harbor the Dhp side chain of the sub-
strate and the Hpu product. The electrostatic potential of thereserved
Figure 6. The Substrate-Binding Cavity of
hDOHH
(A) View into the substrate funnel, onto the
constriction at Tyr60, Tyr211, Glu241, Glu244, and
Glu57, which forms the mouth of the inner cavity,
the binding site for Dhp and Hpu.
(B) The shape of the cavity and its environment.
(C) Surface electrostatics of hDOHH colored from
red (negative potential) to blue (positive potential).
The circle indicates the outer rim of the binding
site.
(D) As in (C), for human eIF-5A (PDB code 1FH4)
(Facchiano et al., 2001). The presumed interacting
region of eIF-5A is indicated by the rectangle. Two
orientations of the eIF-5A molecule are shown.substrate-binding site is negative in both the inner and the
external cavities (Figure 6C), in agreement with the long,
basic side chain of Dhp and the very basic, exposed hydro-
philic loop (KTGK50HGHAK) of the substrate, Dhp-eIF-5A
(Figure 6D).
A Model for Dhp-eIF-5A Binding to hDOHH
In order to build a binding model of Dhp/Hpu in the active center
of hDOHH, an automated docking experiment was carried out as
part of this study. Dhp and Hpu were docked to hDOHH by using
AutoDock (Morris et al., 2009). The results show that the side
chain of the Dhp/Hpu residue is neatly accommodated by the in-
ner cavity of hDOHH (Figures 7A and 7B). In the modeled Dhp
complex, the terminal ammonium group of Dhp forms strong
hydrogen bonds with the Oε2 atoms of Glu93 and Glu208, and
its Nε atom hydrogen bonds with Glu241 Oε2 (Figure 7A).
Compared with the hDOHH-Dhp (substrate) complex, the struc-
ture of the hDOHH-Hpu (product) complex shows some inter-
esting differences. The Hpu moves slightly out from the inner
cavity (Figure 7B). The terminal ammonium group of Hpu
switches to Glu93 Oε2 and the hydroxyl group of Hpu forms a
hydrogen bond with Glu90 Oε2 (Figure 7B). Upon hydroxylation,
the modified carbon atom moves from near Fe1 in the hDOHH-
Dhp complex to a position in the middle between the two iron
atoms, above the diiron site (Figures 7A and 7B). These docking
results are in good agreement with the previous observation of
an essential role of Glu90, Glu208, and Glu241 for substrate
binding (Kang et al., 2007).
Although a large polypeptide (residues 20–90) around the
Dhp residue in eIF-5A is needed for an effective enzyme-sub-
strate interaction (Kang et al., 2007), the docking results withStructure 23, 882–892, May 5, 2015Dhp and Hpu alone still provide many
hints for understanding the molecular in-
teractions between hDOHH and its only
substrate, Dhp-eIF-5A, and they are in
agreement with the substrate-binding in-
formation obtained from mutagenesis
experiments and from our crystal struc-
tures. In addition, we observed that the
binding mode of glycerol in our GLC
structure superimposes perfectly with
the terminus of Hpu (terminal three car-
bons) in the docked structure (Figures7B and 7C); thus, glycerol can be considered a model for the
product of the DOHH reaction.
Conclusions
DOHH is a non-heme diiron enzyme that catalyzes the second
and last step of the posttranslational modification of eIF-5A.
Mo¨ssbauer spectra demonstrated that our recombinant
hDOHH preparation contains a relatively homogeneous
peroxo-diiron(III) core. This peroxo-diiron(III) intermediate is
extremely stable at 4C, and likely slowly converts to other
peroxo-diiron(III) species at higher temperature. By X-ray crys-
tallography of hDOHHperoxo, we achieved the first visualization
of a native, biological m-1,2-peroxo-diiron(III) core at atomic res-
olution, thereby shedding light on the exact geometry of the
critical intermediate of O2-activating non-heme diiron enzymes.
At the same time, we elucidated the structural basis for the
extreme longevity of the peroxo-diiron(III) intermediate in
hDOHH, namely a histidine-rich primary coordination sphere
lacking bridging carboxylate ligands, and a hydrophobic sec-
ondary coordination hemisphere.
The changes in time-dependent UV/Vis spectra of freshly iso-
lated hDOHH over a period of 48 hr and the slightly different
Mo¨ssbauer spectrum of hDOHH polycrystals harvested after
48 hr, comparedwith that of the fresh preparation (Figure 2), indi-
cate that a discrete peroxo species converted from the one
initially formed after activation by O2. The geometry of the
peroxo-diiron core observed in the POX structure (derived from
a crystal grown in the same time window, 48 hr) displays a rela-
tively loose m-1,2-peroxo-diiron(III) geometry (large Fe-Fe and
Fe-O(peroxo) distances). Very likely, our POX structure repre-
sents a putative secondary peroxo-diiron(III) species, whichª2015 Elsevier Ltd All rights reserved 889
Figure 7. A Model of the hDOHH-Dhp/Hpu Interaction
Carbon, nitrogen, oxygen, and iron atoms are presented in gray, blue, red, and green, respectively. A surface representation of these compounds is also shown.
(A) Docking structure of the hDOHH-Dhp complex.
(B) As in (A), for hDOHH-Hpu.
(C) Glycerol in the substrate cavity in the GLC structure.corresponds to the enzyme agedwithin the timewindow of 48 hr,
as characterized by UV/Vis and Mo¨ssbauer spectroscopy (Fig-
ures 2A and 2C). It is possibly formed by protonation of the
non-protein ligands of the diiron site, likely of an oxygen in the
peroxo ligand. Such protonation has been proposed as the first
step of cleavage of the O-O bond in the well-studied MMOH
system (Solomon et al., 2000; Xue et al., 2008). In order to better
understand the mechanism of DOHH, more diiron intermediates
in the reaction cycle need to be identified.
The electron transfer sequence after the breakdown of
hDOHHperoxo remains unclear. It is likely that hDOHH uses a
mechanism similar to that of sMMOH, since both these en-
zymes catalyze the cleavage of a C-H bond and incorporation
of a hydroxyl group into the hydrocarbon substrate. Following
protonation, the O-O bond is cleaved in sMMOH, yielding a
m-oxo-diiron(IV) core at the active site of the enzyme (compound
Q) (Wallar and Lipscomb, 1996). So far, a high-oxidation-state
diiron species has not been found for hDOHH. Unusually, the
diiron(III) species at the end of the oxidation sequence, which
is normally well characterized for other diiron enzymes, has
not been observed for the hDOHH system. In our glycerol com-
plex (GLC) structure, the two iron atoms are bridged by a puta-
tive hydroxo group, which probably corresponds to the diiron(III)
species of hDOHH in the resting state. In addition, a reduction
system likely required for hDOHH to regenerate the O2-reactive
state (diiron(II) core) remains to be identified.
The crystal structures of hDOHH help in understanding the
specific interaction between hDOHH and Dhp-eIF-5A and
provide a basis for the design of inhibitors that could be
developed into drugs for the treatment of various diseases.
Equally important, they help in understanding the extreme
longevity of the peroxo-diiron(III) intermediate in hDOHH and
will motivate more spectroscopic studies with this remarkable
system.
EXPERIMENTAL PROCEDURES
Expression and Purification
Genes coding for C-terminally truncated hDOHH were cloned into pGEX-6P-1
(GE Healthcare). Site-directed mutagenesis was done using Pfx polymerase890 Structure 23, 882–892, May 5, 2015 ª2015 Elsevier Ltd All rights(Invitrogen). All constructs used for recombinant hDOHH production were
confirmed by sequencing. Escherichia coli BL21 (DE3) cells transformed
with overexpression constructs were grown in 23 YT medium containing
100 mg/ml ampicillin. Expression was induced with 1 mM isopropyl b-D-1-thi-
ogalactopyranoside until OD600 reached 0.6. Protein purification was carried
out at 4C. The bacterial pellet was collected and lysed with 100 ml of lysis
buffer (PBS, 500 mM NaCl [pH 7.4]). Cells resuspended in lysis buffer were
broken by sonication on ice. After ultracentrifugation for 1 hr at 30,000 3 g
and 4C, the supernatant was loaded onto a GST column (GE Healthcare).
The target protein was cleaved on the column by PreScission Protease (GE
Healthcare) overnight and then eluted in Superdex 75 buffer (25 mM Tris-
HCl, 150 mM NaCl [pH 7.5]). After repeated gel filtration, pure holo-hDOHH
was obtained.
For the preparation of 57Fe-hDOHH, 20 mg of 57Fe metal foil were dissolved
in 18%HCl. After removal of HCl, 57Fe3+ dissolved in water was added to 2 l of
M9 minimal medium. The purification protocols were the same as for normal
protein.
UV/Vis Spectra
A first measurement was carried out immediately after protein purification
(following cleavage of the GST tag on the column) (at 4C, 24 hr after
breaking the cells). Around 5 mg/ml wild-type enzyme in Tris-HCl buffer
(25 mM Tris-HCl, 150 mM NaCl [pH 7.5]) was used for time-dependent
UV/Vis spectroscopic measurements. 1 ml of protein solution in a quartz
cuvette was covered by a layer of paraffin oil. The sample was stored at
10C and measured every 2 hr (during the first 12 hr) or every 12 hr
(thereafter).
Mo¨ssbauer Spectra
57Fe-labeled hDOHH in Tris-HCl buffer (see above) or in polycrystalline form
was subjected to Mo¨ssbauer spectroscopy. Four different samples were
measured: freshly isolated enzyme (prepared at 4C), crystals grown from
the fresh enzyme preparation (at 10C, harvested 48 hr after setting up the
crystallization experiment), enzyme in glycerol-containing buffer (stored at
10C for 48 hr), and crystals grown in the presence of 10% glycerol (at
10C, harvested 48 hr after setting up the crystallization experiment). Details
of crystallization and Mo¨ssbauer spectroscopy experiments are presented in
the Supplemental Experimental Procedures.
Crystallographic Studies
Optimized crystallization conditions were 30% polyethylene glycol 6000
(w/v), 400 mM guanidinium hydrochloride (Gdn$HCl), 100 mM Bis-Tris
propane (pH 7.2–7.4). For the GLC complex, Gdn$HCl was replaced by
10%–20% glycerol. 48 hr after setting up the crystallization experiments,
crystals were shock cooled and stored in liquid nitrogen. The structure ofreserved
GLC was determined using the single-wavelength anomalous diffraction
(SAD) method with anomalous dispersion from the iron atoms; the structure
of POX was solved by molecular replacement and GLC as the search
model. Full details of crystallization, data collection, structure determination,
refinement, and validation can be found in the Supplemental Experimental
Procedures.
Automated Docking
Preparation of the target protein structure and the ligands was carried out by
using AutoDock Tools (version 1.5.6) and docking was performed by
AutoDock (version 4.2) (Morris et al., 2009). The crystal structure of hDOHH
(POX) was used as the target protein. Iron ions were included in the docking
grid with their charges set to +1. Iron ligands His56, His89, His207, and
His240 were deprotonated. The grid box included the entire inner cavity and
part of the external cavity. Structures of Dhp and Hpu were created using
the PRODRG server (Schu¨ttelkopf and van Aalten, 2004).
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